Both human papillomavirus (HPV) type 18 and Epstein-Barr virus (EBV) gene sequences were identified in a high and approximately equal proportion of 100 normal, benign, and prostate cancer (PCa) specimens.
Noel J. Whitaker, MD, and colleagues noted in a report in The Prostate that although the apparently ubiquitous presence of these viruses in all three types of tissues suggests that the viruses could be harmless, HPV type 18 in particular has high oncogenic potential and may be associated with some PCa cases. HPV-associated koilocytes were identified in 24% of the PCa specimens studied.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.